SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Return
29.51%
This Quarter Return
-6.56%
1 Year Return
+29.51%
3 Year Return
+13.62%
5 Year Return
+117.76%
10 Year Return
+239.6%
AUM
$855M
AUM Growth
+$250M
(+41%)
Cap. Flow
+$279M
Cap. Flow
% of AUM
32.58%
Top 10 Holdings %
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211
Top Buys
| 1 |
Merck
MRK
|
$11.9M |
| 2 |
Edwards Lifesciences
EW
|
$11.8M |
| 3 |
Intuitive Surgical
ISRG
|
$10.3M |
| 4 |
DocuSign
DOCU
|
$9.35M |
| 5 |
Xylem
XYL
|
$9.1M |
Top Sells
| 1 |
Nasdaq
NDAQ
|
$7.26M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
$6.83M |
| 3 |
Incyte
INCY
|
$6.31M |
| 4 |
Fidelity National Information Services
FIS
|
$5.73M |
| 5 |
AbbVie
ABBV
|
$5.03M |
Sector Composition
| 1 | Technology | 20.41% |
| 2 | Consumer Discretionary | 17.68% |
| 3 | Healthcare | 16% |
| 4 | Industrials | 11.99% |
| 5 | Financials | 8.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Constellation Brands
STZ
$25.7B
| $682K | 0.08% |
+2,713
| New | +$682K |
|
|
ETRN
327
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $681K | 0.08% |
+72,726
| New | +$681K |
|
328
Robert Half
RHI
$3.8B
| $681K | 0.08% |
+9,299
| New | +$681K |
|
329
Valvoline
VVV
$4.95B
| $681K | 0.08% |
+21,118
| New | +$681K |
|
330
Ultragenyx Pharmaceutical
RARE
$3.01B
| $680K | 0.08% |
19,075
+5,271
| +38% | +$188K |
|
331
Vicor
VICR
$2.33B
| $676K | 0.08% |
+11,473
| New | +$676K |
|
332
Ares Management
ARES
$39.5B
| $674K | 0.08% |
+6,551
| New | +$674K |
|
|
SGI
333
Somnigroup International Inc.
SGI
$18.2B
| $667K | 0.08% |
+15,386
| New | +$667K |
|
334
Amcor
AMCR
$19.2B
| $666K | 0.08% |
72,665
+3,143
| +5% | +$28.8K |
|
335
Cintas
CTAS
$83.4B
| $659K | 0.08% |
5,480
+1,032
| +23% | +$124K |
|
336
Arrowhead Research
ARWR
$3.87B
| $658K | 0.08% |
24,474
+11,764
| +93% | +$316K |
|
337
LKQ Corp
LKQ
$8.31B
| $657K | 0.08% |
+13,278
| New | +$657K |
|
338
Enbridge
ENB
$105B
| $657K | 0.08% |
+19,794
| New | +$657K |
|
339
Navitas Semiconductor
NVTS
$1.18B
| $653K | 0.08% |
94,018
+74,737
| +388% | +$519K |
|
340
Petrobras Class A
PBR.A
$73.6B
| $641K | 0.08% |
46,761
-194,413
| -81% | -$2.67M |
|
341
Oxford Industries
OXM
$636M
| $638K | 0.07% |
+6,641
| New | +$638K |
|
342
ASGN Inc
ASGN
$2.3B
| $636K | 0.07% |
+7,784
| New | +$636K |
|
343
GMS Inc
GMS
$4.2B
| $634K | 0.07% |
+9,907
| New | +$634K |
|
344
DT Midstream
DTM
$10.7B
| $630K | 0.07% |
+11,912
| New | +$630K |
|
345
Equinor
EQNR
$60.7B
| $627K | 0.07% |
+19,132
| New | +$627K |
|
|
CBAY
346
DELISTED
Cymabay Therapeutics
CBAY
| $620K | 0.07% |
+41,556
| New | +$620K |
|
347
ScottsMiracle-Gro
SMG
$3.62B
| $616K | 0.07% |
+11,917
| New | +$616K |
|
348
BellRing Brands
BRBR
$5.38B
| $615K | 0.07% |
14,925
+7,716
| +107% | +$318K |
|
349
Veeva Systems
VEEV
$44.3B
| $613K | 0.07% |
+3,014
| New | +$613K |
|
350
Air Products & Chemicals
APD
$64.5B
| $608K | 0.07% |
2,146
+691
| +47% | +$196K |
|